Mpox in the 21st Century

A special issue of Pathogens (ISSN 2076-0817).

Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 1685

Special Issue Editor


E-Mail Website
Guest Editor
Division of Infectious Diseases, Saint Louis University, St. Louis, MO 63103, USA
Interests: mycobacterial diseases (TB and nontuberculous mycobacteria); respiratory viruses (influenza, RSV, COVID-19); pox infections; general clinical infectious diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Mpox is one of the four pathogenic orthopoxvirus species. Mpox has two genetic clades, the Central African and West African clades, which have caused outbreaks in the corresponding regions of Africa since 1970. The first Mpox cases outside Africa were detected in the United States in 2003, suggesting the potential for Mpox clades to spread widely. In fact, Mpox recently caused a large outbreak involving 110 countries and locations that led the World Health Organization to declare a global health emergency in July 2022, illustrating that Mpox continues to be a serious public health threat.

In this Special Issue of Pathogens, we invite you to submit research articles, review articles, short communications, and case series or case reports on Mpox. Suggested topics include, but are not limited to, clinical presentations in individuals with different risk factors; animal reservoirs and transmission; treatment, vaccines and their impact; and ongoing studies for the potential improvement of strategies to control future outbreaks.

Dr. Getahun Abate
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Mpox
  • monkeypox
  • outbreak
  • treatment
  • vaccine

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 1863 KiB  
Review
Mapping the Landscape of Health Research Priorities for Effective Pandemic Preparedness in Human Mpox Virus Disease
by Sumit Aggarwal, Pragati Agarwal, Kuldeep Nigam, Neetu Vijay, Pragya Yadav and Nivedita Gupta
Pathogens 2023, 12(11), 1352; https://doi.org/10.3390/pathogens12111352 - 14 Nov 2023
Viewed by 1324
Abstract
The global re-emergence of monkeypox (Mpox) in non-endemic regions in 2022 has highlighted the critical importance of timely virus detection and robust public health surveillance in assessing outbreaks and their impact. Despite significant Mpox research being conducted worldwide, there is an urgent need [...] Read more.
The global re-emergence of monkeypox (Mpox) in non-endemic regions in 2022 has highlighted the critical importance of timely virus detection and robust public health surveillance in assessing outbreaks and their impact. Despite significant Mpox research being conducted worldwide, there is an urgent need to identify knowledge gaps and prioritize key research areas in order to create a roadmap that maximizes the utilization of available resources. The present research article provides a comprehensive mapping of health research priorities aimed at advancing our understanding of Mpox and developing effective interventions for managing its outbreaks, and, as evidenced by the fact that achieving this objective requires close interdisciplinary collaboration. The key research priorities observed were identifying variants responsible for outbreaks; discovering novel biomarkers for diagnostics; establishing suitable animal models; investigating reservoirs and transmission routes; promoting the One Health approach; identifying targets for vaccination; gaining insight into the attitudes, experiences, and practices of key communities, including stigma; and ensuring equity during public health emergencies. The findings of this study hold significant implications for decision making by multilateral partners, including research funders, public health practitioners, policy makers, clinicians, and civil society, which will facilitate the development of a comprehensive plan not only for Mpox but also for other similar life-threatening viral infections. Full article
(This article belongs to the Special Issue Mpox in the 21st Century)
Show Figures

Figure 1

Back to TopTop